Findings suggest that routine urine drug screening in the ICCU could improve risk stratification, help personalize drug withdrawal support.

A retrospective cohort study found that beta-blocker use is associated with a decreased risk for incident HF in certain SAID populations.

US health officials are proposing a new way to develop and approve custom-made treatments for people with rare and hard-to-treat conditions.

HealthDay News — COVID-19 vaccination, especially with a booster dose, is associated with reduced odds of preeclampsia (PE), according to a study published online Feb. 18 in eClinicalMedicine.

GLP1-RA use may be linked to improved overall survival, but not improved disease-free survival, in breast cancer survivors, researchers report.

For individuals with high BP, baduanjin, a traditional Chinese mind-body practice, can lower SBP, with effects sustained for ...

A new clinical classification system is presented to define the severity of an acute PE and assist in developing adult treatment strategies.

Glucagon-like peptide-1 receptor agonist (GLP-1RA) therapy was associated with reduced Parkinson disease (PD) risk.

Wildfire smoke exposure during pregnancy may increase the risk for autism spectrum disorder (ASD), according to a new study.

The US Food and Drug Administration (FDA) is relaxing a long-standing drug approval requirement for common diseases.

FDA approves swallowable Allurion Gastric Balloon for weight loss in adults with obesity who failed prior lifestyle programs.

Elevated peak donor troponin levels are associated with an increased risk for 1-year graft loss in pediatric heart transplant recipients.